person

Silvio P. S.

Country
Italy
Department
DIDAS Medicina dei sistemi-UOC Clinica Medica V-Medicina interna ad indirizzo Epatologico

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
9
Sites with multiple studies

Has run more than one trial at 9 of 44 partner sites.

Specializations

Liver Disease Management

This investigator specializes in treating advanced liver conditions, with particular emphasis on decompensated cirrhosis and its clinical manifestations. Their research focuses on innovative therapeutic approaches for managing liver dysfunction and its complications.

  • Cirrhotic Liver Disease
  • Hepatic Decompensation
  • Fluid Retention Management

Their work encompasses the evaluation of novel treatment strategies for patients with compromised liver function.

Acute-on-Chronic Liver Failure

The investigator demonstrates particular expertise in ACLF management, focusing on treating patients with various grades of liver failure. Their research extends to investigating therapeutic interventions for hepatic encephalopathy and ascites.

  • ACLF Grading and Treatment
  • Organ Dysfunction Management
  • Systemic Inflammation Control

Their clinical interests include developing treatment protocols for high-mortality risk liver failure cases.

Therapeutic Innovation

The investigator explores cutting-edge treatments including albumin-based therapies and novel pharmaceutical interventions. Their research encompasses the evaluation of combination therapies and innovative medical solutions for liver disease.

  • Albumin Treatment Protocols
  • Fluid Management Strategies
  • Blood Pressure Control

Their work focuses on developing comprehensive treatment approaches for complex hepatic conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.